Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: Real Man who wrote (126763)	10/2/2001 9:18:08 AM
From: rolatzi	Respond to of 436258

At least if EXDS and @home are bankrupt, they will no long cause downward pressure on the average. They should therefore be left in the NAS 100 until the market turns back up again at which time they can be replace by two companies whose share values are increasing. rolatzi

To: Real Man who wrote (126763)	10/2/2001 11:04:44 AM
From: Les H	Respond to of 436258

ADRX Andrx Group will replace ATHM Excite At-Home biz.yahoo.com most of the candidates for inclusion into Nasdaq-100 are Biotech-related or Retailers. They don't seem to have much inclination to add other than tech stocks, although they already include Costco, Starbucks, etc. Biotech candidates for inclusion into Nasdaq-100: AFFX Affymetrix ALKS Alkermes ENZN Enzon ICOS Icos Therapeutics PDLI Protein Design Labs QLTI QLT Phototherapeutics SEPR Sepracor Retailers: AEOS American Eagle APPB Applebee's FAST Fastenal HLYW Hollywood Entertainment PFGC Performance Food Group PNRA Panera's PZZA Pappa John's ROST Ross Stores WFMI Whole Foods The above biotechs could push into the S&P Midcap 400, thereby pushing more of the biotechs above them into the S& P 500.